Arvinas to Present at Jefferies Global Healthcare Conference
Globe Newswire•11/11/2026•07:00 ET
0
Key Highlights
- ➤Arvinas (ARVN) management to present at Jefferies Global Healthcare Conference November 18
- ➤Live webcast scheduled for 9:00 a.m. GMT/4:00 a.m. EST
- ➤Arvinas and Pfizer developed the first FDA-approved PROTAC
- ➤Arvinas advancing investigational drugs across oncology and neurodegenerative disorders
NEW HAVEN, Conn., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, November 18 at 9:00 a.m. GMT/4:00 a.m. EST.
A live audio webcast of the presentation will be available here and under “Events and Presentations” on the Investors and Media section of the Company’s website.
Get started
Create a free account to read the full story.